LGM

Logos Global Management Portfolio holdings

AUM $749M
1-Year Return 18.94%
This Quarter Return
-14.59%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$771M
AUM Growth
-$198M
Cap. Flow
-$49M
Cap. Flow %
-6.35%
Top 10 Hldgs %
57.03%
Holding
73
New
7
Increased
16
Reduced
17
Closed
26

Top Buys

1
NBIX icon
Neurocrine Biosciences
NBIX
$44.5M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$24.7M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
$24.1M
4
ASND icon
Ascendis Pharma
ASND
$20.5M
5
GBT
Global Blood Therapeutics, Inc.
GBT
$17.3M

Top Sells

1
ALGS icon
Aligos Therapeutics
ALGS
$36.9M
2
RPTX icon
Repare Therapeutics
RPTX
$35.9M
3
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$22.8M
4
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$15.5M
5
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
$14.6M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IPSC icon
26
Century Therapeutics
IPSC
$40.4M
$6.93M 0.9%
550,259
-63,836
-10% -$804K
CNTA
27
Centessa Pharmaceuticals
CNTA
$2.13B
$4.08M 0.53%
454,545
– –
TIL icon
28
Instil Bio
TIL
$194M
$4.05M 0.53%
+18,855
New +$4.05M
TRML icon
29
Tourmaline Bio
TRML
$642M
$3.01M 0.39%
30,624
-2,277
-7% -$224K
TYRA icon
30
Tyra Biosciences
TYRA
$649M
$2.7M 0.35%
252,726
-220,668
-47% -$2.36M
VERV
31
DELISTED
Verve Therapeutics
VERV
$2.21M 0.29%
96,912
-346,353
-78% -$7.91M
CGEM icon
32
Cullinan Oncology
CGEM
$393M
$2.09M 0.27%
200,000
-88,458
-31% -$926K
EWTX icon
33
Edgewise Therapeutics
EWTX
$1.52B
$2.07M 0.27%
213,744
-636,256
-75% -$6.17M
SPRB
34
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.01M 0.26%
1,000,000
-100,000
-9% -$201K
NUVL icon
35
Nuvalent
NUVL
$5.73B
$1.87M 0.24%
134,650
– –
LIAN
36
DELISTED
LianBio American Depositary Shares
LIAN
$1.53M 0.2%
412,837
– –
VRNA
37
Verona Pharma
VRNA
$9.18B
$1.5M 0.19%
300,000
+178,000
+146% +$888K
VIGL
38
DELISTED
Vigil Neuroscience
VIGL
$1.45M 0.19%
+205,595
New +$1.45M
VTGN icon
39
VistaGen Therapeutics
VTGN
$113M
$1.24M 0.16%
33,333
-33,334
-50% -$1.24M
PYXS icon
40
Pyxis Oncology
PYXS
$93M
$1.16M 0.15%
286,652
– –
COGT icon
41
Cogent Biosciences
COGT
$1.81B
$1.12M 0.15%
150,000
– –
IMA
42
ImageneBio, Inc. Common Stock
IMA
$116M
$1.09M 0.14%
14,857
-10,131
-41% -$742K
BMEA icon
43
Biomea Fusion
BMEA
$108M
$892K 0.12%
200,000
-52,320
-21% -$233K
SLGC
44
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$802K 0.1%
100,000
-100,493
-50% -$806K
RAIN
45
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$680K 0.09%
134,194
-110,967
-45% -$562K
OMGA
46
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$81K 0.01%
12,986
-75,249
-85% -$469K
NUVB.WS icon
47
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$71.5M
$54K 0.01%
66,666
– –
ALGS icon
48
Aligos Therapeutics
ALGS
$69.9M
– –
-124,511
Closed -$36.9M
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$59.9B
– –
-35,000
Closed -$5.94M
CMPS
50
Compass Pathways
CMPS
$463M
– –
-300,000
Closed -$6.63M
1
2
3